Overlap of Genetic Loci for Central Serous Chorioretinopathy With Age-Related Macular Degeneration.
Saved in:
| Title: | Overlap of Genetic Loci for Central Serous Chorioretinopathy With Age-Related Macular Degeneration. |
|---|---|
| Authors: | Rämö JT; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Massachusetts Eye and Ear, Boston.; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cardiovascular Research Center, Massachusetts General Hospital, Boston., Abner E; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands., van Dijk EHC; Estonian Genome Center, University of Tartu, Tartu, Estonia., Wang X; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Brinks J; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands., Nikopensius T; Estonian Genome Center, University of Tartu, Tartu, Estonia., Nõukas M; Estonian Genome Center, University of Tartu, Tartu, Estonia.; Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia., Marjonen H; Finnish Institute for Health and Welfare, Helsinki, Finland., Silander K; Finnish Institute for Health and Welfare, Helsinki, Finland., Jukarainen S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Kiiskinen T; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Choi SH; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Biostatistics, Boston University, Boston, Massachusetts., Kajanne R; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Mehtonen J; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Palta P; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands., Lubitz SA; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston., Kaarniranta K; Department of Ophthalmology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland., Sobrin L; Harvard Medical School Department of Ophthalmology, Massachusetts Eye and Ear, Boston., Kurki M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston., Yzer S; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands., Ellinor PT; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston., Esko T; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.; Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia., Daly MJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., den Hollander AI; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands.; Genomics Research Center, AbbVie, Cambridge, Massachusetts., Palotie A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Neurology, Massachusetts General Hospital, Boston.; Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston., Turunen JA; Folkhälsan Research Center, Biomedicum, Helsinki, Finland.; Department of Ophthalmology, University of Helsinki, Helsinki, Finland., Boon CJF; Estonian Genome Center, University of Tartu, Tartu, Estonia.; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Rossin EJ; Harvard Medical School Department of Ophthalmology, Massachusetts Eye and Ear, Boston.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts. |
| Corporate Authors: | FinnGen Study, Estonian Biobank Research Team |
| Source: | JAMA ophthalmology [JAMA Ophthalmol] 2023 May 01; Vol. 141 (5), pp. 449-457. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6173 |
|---|---|
| DOI: | 10.1001/jamaophthalmol.2023.0706 |
